Stopping RAS inhibitors tied to worse outcomes in patients with advanced chronic kidney disease
Small studies have suggested that RAS inhibitors may be harmful in persons with advanced chronic kidney disease, and physicians therefore often stop the treatment in such patients.
Newer Type 2 diabetes medications have heart and kidney disease benefits, too
Two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD)…
Beta-blockers reduce death in patients with heart failure and moderate renal impairment
Beta-blockers remain effective for preventing death in heart failure with reduced ejection fraction (HFrEF) and sinus rhythm, even in patients with moderate or moderately-severe kidney dysfunction, according to…
Smoking While Pregnant May Compromise Children’s Kidney Function
The effects of smoking on kidney health were evident in 3-year-old children.